CVS Health Corporation (NYSE:CVS) Position Boosted by Achmea Investment Management B.V.

Achmea Investment Management B.V. increased its position in CVS Health Corporation (NYSE:CVS - Free Report) by 23.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 130,810 shares of the pharmacy operator's stock after purchasing an additional 24,667 shares during the quarter. Achmea Investment Management B.V.'s holdings in CVS Health were worth $8,862,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Hopwood Financial Services Inc. bought a new position in CVS Health during the 4th quarter valued at $29,000. McIlrath & Eck LLC boosted its stake in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Providence First Trust Co bought a new position in CVS Health during the 4th quarter valued at $42,000. Park Square Financial Group LLC bought a new position in CVS Health during the 4th quarter valued at $43,000. Finally, PARK CIRCLE Co boosted its stake in CVS Health by 42.9% during the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after acquiring an additional 300 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Robert W. Baird increased their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Royal Bank Of Canada increased their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Truist Financial increased their target price on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Finally, Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Stock Performance

Shares of CVS stock traded up $0.36 during trading hours on Friday, reaching $68.50. The stock had a trading volume of 5,937,044 shares, compared to its average volume of 10,868,418. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The firm has a 50-day simple moving average of $64.86 and a 200-day simple moving average of $60.79. The firm has a market capitalization of $86.66 billion, a PE ratio of 16.35, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.